Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8680252 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2018 | 8 Pages |
Abstract
Findings demonstrate a risk of disproportionate focus on possible benefits of testing among amyloid scan candidates and suggest a need to clearly emphasize the limitations of amyloid PET when counseling cognitively impaired patients and their families before testing. Future research should examine whether minimizing drawbacks at the pre-imaging stage has adverse consequences on results disclosure.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jennifer H. Lingler, J. Scott Roberts, Hyejin Kim, Jonna L. Morris, Lu Hu, Meghan Mattos, Eric McDade, Oscar L. Lopez,